3Mendelson G,Hait V,Ben-Israel J,Gronich D,Granot E,Raz R.Prevalence and risk factors of extended-spectrum beta-lactamaseproducing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility[J].Eur J Clin Microbiol Infect Dis,2005,24(1):17-22.
4Lucet JC, Decre D, Fichelle A, Joly-Guillou ML, Pernet M, Deblangy C, et al. Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital [J]. Clin Infect Dis, 1999, 29(6): 1411-1418.
5Pena C,Pujol M,Ardanuy C,Ricart A,Pallares R,Linares J,et al.Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases [J]. Antimicrob Agents Chemother, 1998, 42(1): 53-58.
6Medeiros AA. Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics [J]. Clin Infect Dis, 1997, 24 (Suppl 1): S19-S45.
7Jacoby GA , Han P . Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli [J]. Clin Microbiol, 1996, 34(4): 908-911.
8Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiellapneumoniae: risk factors for infection and impact of resistance on outcomes [J]. Clin Infect Dis, 2001, 15; 32(8): 1162-1171.
9Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins [J]. Ann Intern Med, 1993,119(5): 353-358.
10Rupp ME,Fey PD.Extended spectrum β-Lactamase(ESBL)-producing Enterobacteriaceae considerations for diagnosis ,prevention and drug treatment.Drugs,2003;64(4):353～65.
